Scrap Report
—
Mark Bouzyk is a biotechnology executive, scientist, and entrepreneur with over 30 years of experience advancing genetics, genomics, and precision medicine across global pharmaceutical companies, academic institutions, and high-growth biotech startups. His work spans pharmacogenomics, oncology, biomarker discovery, and digital health, and he is dedicated to translating scientific innovation into practical clinical solutions.